252 related articles for article (PubMed ID: 24424522)
1. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.
Guabiraba R; Besnard AG; Menezes GB; Secher T; Jabir MS; Amaral SS; Braun H; Lima-Junior RC; Ribeiro RA; Cunha FQ; Teixeira MM; Beyaert R; Graham GJ; Liew FY
Mucosal Immunol; 2014 Sep; 7(5):1079-93. PubMed ID: 24424522
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota.
Bai X; Deng J; Duan Z; Fu R; Zhu C; Fan D
Phytomedicine; 2024 Jun; 128():155577. PubMed ID: 38608488
[TBL] [Abstract][Full Text] [Related]
4. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
[TBL] [Abstract][Full Text] [Related]
5. IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21(WAF1) and p27(KIP1.).
Wang X; Zhu S; Qian L; Gao J; Wu M; Gao J; Zhang Y; Chan GL; Yu Y; Han W
Pharmacol Res; 2014 Apr; 82():21-33. PubMed ID: 24681512
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
[TBL] [Abstract][Full Text] [Related]
7. Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis.
Fakiha K; Coller JK; Logan RM; Gibson RJ; Bowen JM
Support Care Cancer; 2019 Jun; 27(6):2313-2320. PubMed ID: 30350190
[TBL] [Abstract][Full Text] [Related]
8. Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice.
Alvarenga EM; Sousa NA; de Araújo S; Júnior JLP; Araújo AR; Iles B; Pacífico DM; Brito GAC; Souza EP; Sousa DP; Medeiros JVR
J Pharm Pharmacol; 2017 Dec; 69(12):1773-1785. PubMed ID: 28940490
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
[TBL] [Abstract][Full Text] [Related]
10. Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis.
Wang X; Gao J; Qian L; Gao J; Zhu S; Wu M; Zhang Y; Guan W; Ye H; Yu Y; Han W
Anticancer Drugs; 2015 Jan; 26(1):35-45. PubMed ID: 24999837
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
[TBL] [Abstract][Full Text] [Related]
12. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.
Ikuno N; Soda H; Watanabe M; Oka M
J Natl Cancer Inst; 1995 Dec; 87(24):1876-83. PubMed ID: 7494232
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
[TBL] [Abstract][Full Text] [Related]
14. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
[TBL] [Abstract][Full Text] [Related]
15. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC
BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor (HGF), heat shock proteins (HSPs) and multidrug resistance protein (MRP) expression in co-culture of colon tumor spheroids with normal cells after incubation with interleukin-1beta (IL-1beta) and/or camptothecin (CPT-11).
Paduch R; Jakubowicz-Gil J; Niedziela P
Indian J Exp Biol; 2010 Apr; 48(4):354-64. PubMed ID: 20726333
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model.
Cao S; Black JD; Troutt AB; Rustum YM
Cancer Res; 1998 Aug; 58(15):3270-4. PubMed ID: 9699654
[TBL] [Abstract][Full Text] [Related]
18. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
[TBL] [Abstract][Full Text] [Related]
19. Preventative effects of selenium-enriched
Qiu Y; Zhang J; Ji R; Zhou Y; Shao L; Chen D; Tan J
Benef Microbes; 2019 May; 10(5):569-577. PubMed ID: 30964326
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
